Dermapharm Holding SE (DMP) — Financial Flexibility Index
Dermapharm Holding SE (DMP) has a Financial Flexibility Index of 0.03x as of March 2026. Free cash flow of €51.34 Million (operating CF €39.49 Million minus capex €11.85 Million) represents 0% of total liabilities (€1.54 Billion). Check DMP capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Dermapharm Holding SE Financial Flexibility Index (2014–2025)
Historical Financial Flexibility Index trend for Dermapharm Holding SE across 12 annual periods. See DMP net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Dermapharm Holding SE (2014–2025)
Year-by-year free cash flow to debt coverage for Dermapharm Holding SE. For the full company profile including market capitalisation, see market cap of Dermapharm Holding SE.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.15x | €223.63 Million | €181.51 Million | €1.50 Billion | ▼ -8.6% |
| 2024 | 0.16x | €239.62 Million | €201.38 Million | €1.47 Billion | ▲ +0.8% |
| 2023 | 0.16x | €260.96 Million | €219.42 Million | €1.62 Billion | ▼ -56.6% |
| 2022 | 0.37x | €327.55 Million | €288.53 Million | €880.34 Million | ▲ +8.3% |
| 2021 | 0.34x | €311.57 Million | €250.37 Million | €907.13 Million | ▲ +79.8% |
| 2020 | 0.19x | €171.89 Million | €131.10 Million | €899.81 Million | ▼ -1.2% |
| 2019 | 0.19x | €147.06 Million | €100.61 Million | €760.38 Million | ▼ -53.1% |
| 2018 | 0.41x | €185.10 Million | €159.13 Million | €448.50 Million | ▼ -12.7% |
| 2017 | 0.47x | €161.45 Million | €86.74 Million | €341.62 Million | ▲ +25.4% |
| 2016 | 0.38x | €94.54 Million | €76.78 Million | €250.89 Million | ▲ +71.8% |
| 2015 | 0.22x | €55.31 Million | €40.38 Million | €252.22 Million | ▼ -21.3% |
| 2014 | 0.28x | €82.68 Million | €54.26 Million | €296.59 Million | — |